Navigation Links
Portola Pharmaceuticals Presents Positive Phase I Data of Its ADP,Receptor Antagonist at the American College of Cardiology

NEW ORLEANS, March 28, 2007 /PRNewswire/ -- Portola Pharmaceuticals, Inc. presented Phase I data of its ADP receptor antagonist at the of Cardiology's (ACC) 56th Annual Scientific Session this week. Portola's reversible antiplatelet compound, PRT060128, appeared safe and well-tolerated in this study and achieved high-level platelet inhibition.

Portola presented the data in a poster session titled "First in Human Experience with PRT060128, a New Direct-acting, Reversible P2Y(12) Inhibitor for IV and Oral Use" which describes the single ascending dose (SAD) study of the oral formulation of PRT060128. In this study, dose dependent and full inhibition of ADP-induced platelet aggregation was achieved. In addition, following administration of PRT060128, inhibition of platelet aggregation was fully reversed within 24 hours post dosing. All doses of PRT060128 were well tolerated. There were no serious adverse events and no discontinuations due to an adverse event.

"Successful results from both our Phase I oral and intravenous studies build a strong foundation for advancing PRT060128 in the clinic," said Dan Gretler, MD, Portola's vice president of Clinical Development and Regulatory Affairs. "We will initiate our Phase II clinical program later this year to further study the differentiated properties of our ADP receptor antagonist."

Portola's ADP Receptor Antagonist

PRT060128 is an antiplatelet drug that is the only intravenous (IV) and oral ADP receptor antagonist in clinical development. Portola believes that this compound may provide significant clinical benefit through immediate, high-level platelet inhibition in the acute setting and a seamless transition to predictable, reversible platelet inhibition in the chronic setting. Portola has studied this compound in a robust Phase I clinical development program including single ascending dose and multiple ascending dose studies with the oral
'"/>




Page: 1 2

Related medicine technology :

1. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
3. Portola Pharmaceuticals Announces Positive Phase II Results for PRT054021 for Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
Post Your Comments:
(Date:9/29/2014)... 29, 2014  On Oct. 2, some 24,000 Lilly ... company,s seventh Global Day of Service. Building on Lilly,s ... together in a single, coordinated effort to improve the ... "I,m so proud of this tradition, and of ... to strengthening the communities around the world where we ...
(Date:9/29/2014)... SANTA ANA, Calif. , Sept. 29, 2014 /PRNewswire/ ... premier supplier of certified child-resistant packaging, accessories and consulting ... that company co-founder Nick Kovacevich has assumed ... Kovacevich, who co-founded the company in 2010 and worked ... company after a brief hiatus focusing on other ventures. ...
(Date:9/29/2014)... N.J. , Sept. 29, 2014  ADM ... that it has entered into an affiliation with ... in Cambridge, Massachusetts founded ... appointed member of ADMT,s Advisory Board. ... medical technology companies with specialized services and finances ...
Breaking Medicine Technology:Lilly's seventh Global Day of Service rallies 24,000 employees in nearly 60 countries 2Lilly's seventh Global Day of Service rallies 24,000 employees in nearly 60 countries 3Kush Bottles Co-Founder Steps into Role of CEO 2ADM Tronics Joins Triotech Ventures Technology Consortium 2ADM Tronics Joins Triotech Ventures Technology Consortium 3
(Date:9/30/2014)... 30, 2014 Loffler Companies, an ... technology and services was recognized by BEI as ... (FCE) in 2013. This prestigious rating means that ... time and for an extended period following, optimizing ... 20 years BEI Services has been the trusted ...
(Date:9/30/2014)... Julie Kuriakose, MD; Physician, ... will discuss how restaurants can become more allergy-friendly and ... restrictions at the 2014 Allergy Eats Food Allergy ... 21 in New York City. , “I’m extremely delighted ... such an engaged industry audience. As food allergies become ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Up to ... in the United States alone have sleep apnea. Of ... of those treated, many cannot tolerate their prescribed medical ... through a nasal mask) – which supports the airway ... sleep has become especially valuable, and increasingly difficult to ...
(Date:9/30/2014)... vitamin D3 compared with placebo did not reduce hospital ... stay, hospital mortality, or the risk of death at ... were critically ill, according to a study published in ... online to coincide with its presentation at the European ... A high prevalence of low vitamin D levels has ...
(Date:9/30/2014)... 2014 Youth Town’s annual BBQ/Music Festival ... to 2 p.m. at the Youth Town campus (3641 ... sponsors this family-oriented festival, which will offer music, food ... feature a car show, arts and crafts fair, music, ... games. Also, Lightning McQueen and Mater from the hit ...
Breaking Medicine News(10 mins):Health News:Loffler Companies Rated Number One Among U.S. Dealers in Service “First Call Effectiveness” 2Health News:Loffler Companies Rated Number One Among U.S. Dealers in Service “First Call Effectiveness” 3Health News:Hudson Allergy’s Dr. Julie Kuriakose to Speak at Prestigious Food Allergy Conference in New York City 2Health News:Hudson Allergy’s Dr. Julie Kuriakose to Speak at Prestigious Food Allergy Conference in New York City 3Health News:Snoring: Robs People and Their Bed Partners of the Rest They Need to Face Daily Challenges 2Health News:Snoring: Robs People and Their Bed Partners of the Rest They Need to Face Daily Challenges 3Health News:High-dose vitamin D for ICU patients who are vitamin D deficient does not improve outcomes 2
... ... the community, i98FM and ahm are paying tribute to local people helping and inspiring others. ... (PRWEB) June 5, 2010 ... the 2010 i98FM / ahm Local Hero Awards., , , , ,In a joint effort ...
... ... oil spill, Bode & Grenier, LLP announces the release of the revised edition of The Oil ... ... 2010 BP/Deepwater Horizon oil spill, the law firm of Bode & Grenier, LLP announced today that ...
... Ill. According to new research that will be presented ... the American Academy of Dental Sleep Medicine, the majority of ... screen for sleep disorders, which affect more than 70 million ... of California - Los Angeles (UCLA) School of Dentistry surveyed ...
... According to new research that will receive the Graduate ... 19th Annual Meeting of the American Academy of Dental ... enclosure size in patients with obstructive sleep apnea (OSA) ... Although mandibular advancement splints (MAS) have been shown to ...
... ... walk in tub available. And now clients can purchase this walk in tub for the same ... ... the newest and strongest acrylic walk in tub available. And now clients can purchase this walk ...
... ... (off East 23rd Street),New York, NY, NY 10010 ,Date: June 8, 2010,Time: 6 ... special Summer Bash celebration at Solar One. The gathering is expected to ... energy, design, fashion, retailing, finance and consulting. Green Mountain is the first ...
Cached Medicine News:Health News:i98 Fm And ahm Announce Local Hero Finalists 2Health News:i98 Fm And ahm Announce Local Hero Finalists 3Health News:Revised Edition of the Oil Pollution Act Case Digest and Source Book Released 2Health News:US dental schools leave graduates unprepared to screen for sleep disorders 2Health News:Tongue measurements may help dentists determine oral appliance therapy success for sleep apnea 2Health News:The Walkinbathtub1 Factory After Years in Design Has Released the Most Up to date Acrylic Walk in Tub in the World 2Health News:The Walkinbathtub1 Factory After Years in Design Has Released the Most Up to date Acrylic Walk in Tub in the World 3Health News:Green Drinks NYC and Green Mountain Energy Company Present Summer Bash at Solar One 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: